Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
Assuntina G Sacco,1 Francis P Worden2 1Department of Internal Medicine, Division of Hematology/Oncology, University of California at San Diego Moores Cancer Center, La Jolla, CA, USA; 2Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Health System, Ann Arbor,...
Main Authors: | Sacco AG, Worden FP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/molecularly-targeted-therapy-for-the-treatment-ofnbsphead-and-neck-can-peer-reviewed-article-OTT |
Similar Items
-
Targeted therapy: A novel approach in head and neck cancer
by: A Winnifred Christy, et al.
Published: (2013-01-01) -
GGTI-298 in Combination with EGFR Inhibitors: Evaluating a Novel Therapy in Head and Neck Squamous Cell Carcinomas
by: Zahr, Stephanie
Published: (2013) -
GGTI-298 in Combination with EGFR Inhibitors: Evaluating a Novel Therapy in Head and Neck Squamous Cell Carcinomas
by: Zahr, Stephanie
Published: (2013) -
Targeting ErbB3 Receptor in Cancer with Inhibitory Antibodies from Llama
by: Igor E. Eliseev, et al.
Published: (2021-08-01) -
Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer
by: Richard L. Schroeder, et al.
Published: (2014-09-01)